TABLE 2.
Study | Cohort Size | Mean Age (years) | Medical Status | COVID Confirmation Method and Severity | Retina Signs | OCT Abnormalities | Detailed Findings |
---|---|---|---|---|---|---|---|
Sim et al.35 | 108 | 36.4 | Not hospitalized | RT-PCR, mild | 11.6% combined | Microhemorrhages (n = 6)Vascular tortuosity (n = 3)Cotton wool spots (n = 1)GC-IPL hyperreflective plaques (n = 10) | |
Pirraglia et al.34 | 46 | 70 | Hospitalized | RT-PCR, mild to severe | 0% | x | No fundus abnormalities |
Landecho et al.32 | 27 | 56 | Discharged | Positive antibodies, moderate (n = 26)severe (n = 1) | 22% combined | CWS (n = 6) | |
Lani-Louzada et al.33 | 25 | 51.2 | Hospitalized | RT-PCR, moderate to severe | 12% | x | CWS and microhemorrhages (n = 1)Flame hemorrhages (n = 1)Microhemorrhages (n = 1) |
Pereira et al.29 | 18 | 62.5 | Hospitalized | RT-PCR, severe | 55.60% | x | Flame hemorrhages (n = 4)CWS (n = 4)Flame hemorrhages and CWS (n = 1)Peripheral hemorrhages (n = 2) |
Marinho et al.13 | 12 | 25-69 | Not hospitalized | RT-PCR (n = 9), antibodies (n = 2), mild | 100% combined | GCIPL plaques (n = 12) CWS (n = 4)Microhemorrhages (n = 4) | |
Costa et al. 28 | 64 | 46.7-55.6 | Hospitalized | RT-PCR, mild to moderate (n = 7), severe (n = 33), critical (n = 24) | 17.2% | x | Vascular tortuosity (n = 11) |
Bypareddy et al. 31 | 138 | 38.5 | Hospitalized | RT-PCR, mild to moderate | 0.72% | x | Flame hemorrhage (n = 1) |
Caporossi et al.36 | 28 | 39 to 82 | Hospitalized | Not defined, ICU ARDS COVID-19, severe | 28.6% | x | Intraretinal microvascular abnormalities, arterial saccular dilatation, CWS, and microhemorrhages (n = 8) |
Abbreviations: OCT = optical coherence tomography, RT-PCR = reverse transcriptase polymerase chain reaction, GC-IPL = ganglion cell-inner plexiform layer, CWS = cotton wool spots, ARDS = adult respiratory distress syndrome